- Home
- KPTI vs BANX Comparison
KPTI vs BANX Comparison
Compare KPTI & BANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KPTI | BANX |
|---|---|---|
| Founded | 2008 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 172.6M | 154.9M |
| IPO Year | 2013 | 2013 |
Fundamental Metrics
Financial Performance| Metric | KPTI | BANX |
|---|---|---|
| Price | $8.27 | $19.24 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $15.40 | N/A |
| AVG Volume (30 Days) | ★ 803.4K | 68.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $146,067,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $46.62 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 0.57 | N/A |
| 52 Week Low | $3.51 | $17.99 |
| 52 Week High | $10.99 | $23.67 |
Technical Indicators
Market Signals| Indicator | KPTI | BANX |
|---|---|---|
| Relative Strength Index (RSI) | 46.66 | 35.57 |
| Support Level | $5.60 | N/A |
| Resistance Level | $8.95 | $20.93 |
| Average True Range (ATR) | 0.70 | 0.27 |
| MACD | -0.21 | -0.02 |
| Stochastic Oscillator | 0.36 | 52.63 |
Price Performance
Historical ComparisonAbout KPTI Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).
About BANX ArrowMark Financial Corp.
ArrowMark Financial Corp is a non-diversified, closed-end management investment company. Its objective is to provide stockholders with current income, and to a lesser extent capital appreciation. The company's investments in various portfolios such as debt securities, Trust Preferred and Preferred Securities, preferred securities, exchange-traded funds, money market funds and others.